These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2544926)

  • 1. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
    Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
    Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Smith EF; Griswold DE; Egan JW; Hillegass LM; DiMartino MJ
    J Cardiovasc Pharmacol; 1989 May; 13(5):715-22. PubMed ID: 2472519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.
    Smith EF; Nichols AJ; Sellers TS; O'Brien SR; Griswold DE; Egan JW; Hillegass LM; Vasko JA; Slivjak MJ; Davis PA
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):729-38. PubMed ID: 1723770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
    Smith EF; Egan JW; Griswold DE
    Pharmacology; 1989; 38(5):298-309. PubMed ID: 2527373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of captopril to attenuate myocardial damage, neutrophil accumulation, and mortality following coronary artery occlusion and reperfusion in rat.
    Leor J; Varda-Bloom N; Hasdai D; Ovadia Z; Battler A
    Angiology; 1994 Aug; 45(8):717-24. PubMed ID: 8048781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock.
    Lento PH; Saukkonen K; Aoki N; Lefer AM; Slivjak MJ; Smith EF
    Eur J Pharmacol; 1989 Jun; 165(2-3):241-9. PubMed ID: 2550251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556.
    Altavilla D; Squadrito F; Campo GM; Saitta A; Squadrito G; Quartarone C; Deodato B; Arlotta M; Ferlito M; Minutoli L; Tringali M; Urna G; Sardella A; Caputi AP
    Life Sci; 2000 Oct; 67(21):2615-29. PubMed ID: 11104363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
    Smith EF; Slivjak MJ; Eckardt RD; Newton JF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
    Smith EF; Slivjak MJ; Egan JW; Eckardt RD; Newton JF
    Br J Pharmacol; 1990 Jun; 100(2):195-200. PubMed ID: 2165834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-selectin in the pathogenesis of experimental myocardial ischemia-reperfusion injury.
    Altavilla D; Squadrito F; Ioculano M; Canale P; Campo GM; Zingarelli B; Caputi AP
    Eur J Pharmacol; 1994 Jan; 270(1):45-51. PubMed ID: 7512508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender specific effect of progesterone on myocardial ischemia/reperfusion injury in rats.
    Dhote VV; Balaraman R
    Life Sci; 2007 Jun; 81(3):188-97. PubMed ID: 17585947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Faggiotto A; Caputi AP
    Agents Actions; 1993 Jul; 39(3-4):143-9. PubMed ID: 8304242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Campo GM; Arlotta M; Quartarone C; Ferlito M; Caputi AP
    Eur J Pharmacol; 1999 Jan; 364(2-3):159-68. PubMed ID: 9932719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats.
    Ioculano M; Squadrito F; Altavilla D; Canale P; Campo GM; Bussolino F; Sardella A; Urna G; Caputi AP
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):7-12. PubMed ID: 7511738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R.
    Liu P; Xu B; Cavalieri TA; Hock CE
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2719-27. PubMed ID: 15358609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of IRFI-016, a new antioxidant agent, in myocardial damage, following coronary artery occlusion and reperfusion in the rat.
    Campo GM; Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Pollicino AM; Rizzo A; Calapai G; Calandra S; Scuri R
    Pharmacology; 1994 Mar; 48(3):157-66. PubMed ID: 8153143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP
    J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury.
    Deodato B; Altavilla D; Squadrito G; Campo GM; Arlotta M; Minutoli L; Saitta A; Cucinotta D; Calapai G; Caputi AP; Miano M; Squadrito F
    Br J Pharmacol; 1999 Dec; 128(8):1683-90. PubMed ID: 10588923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.